Vera Therapeutics, Inc. (VERA)
49.21
-0.59
(-1.18%)
USD |
NASDAQ |
Dec 15, 16:00
48.90
-0.31
(-0.63%)
Pre-Market: 07:59
Vera Therapeutics Shareholders Equity (Quarterly): 398.88M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Insmed, Inc. | 945.57M |
| Madrigal Pharmaceuticals, Inc. | 625.73M |
| Krystal Biotech, Inc. | 1.138B |
| Olema Pharmaceuticals, Inc. | 307.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 517.50M |
| Total Liabilities (Quarterly) | 118.62M |
| Debt to Equity Ratio | 0.1936 |
| Current Ratio | 12.09 |
| Net Debt Paydown Yield | -0.26% |